Product image of Moloxin (Moxifloxacin) supplied by GNH India

Moloxin

Active Ingredient:
Moxifloxacin
Origin:
EU

Moloxin (Moxifloxacin)

Moxifloxacin, the active ingredient in Moloxin, is a fluoroquinolone presented as an oral tablet for systemic use. It is indicated for the treatment of community‑acquired pneumonia, acute bacterial sinusitis and acute exacerbations of chronic bronchitis in adult patients.
GNH India supplies Moloxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacin is a broad‑spectrum antibacterial that targets respiratory infections and related bacterial diseases.

  • Community‑acquired pneumonia: provides effective bacterial eradication to resolve pulmonary infection.
  • Acute bacterial sinusitis: reduces sinus inflammation by eliminating causative pathogens.
  • Acute exacerbations of chronic bronchitis: helps restore airway function by treating bacterial flare‑ups.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the supercoiling and separation of bacterial DNA, leading to inhibition of bacterial cell division and ultimately bacterial cell death. This bactericidal action is effective against a wide range of Gram‑positive and Gram‑negative organisms.

Side Effects

Moxifloxacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, occasionally watery.
  • Headache: transient cranial discomfort.
  • Dizziness: sensation of light‑headedness.
  • Abdominal pain: cramping or discomfort in the stomach area.
  • Vomiting: occasional expulsion of stomach contents.

Serious or Rare Side Effects

  • Tendon rupture: sudden tendon pain or rupture, especially in the Achilles.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Clostridioides difficile infection: severe colitis with watery diarrhea.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Photosensitivity: increased skin sensitivity to sunlight.

Precautions & Warnings

Before prescribing Moloxin, clinicians should consider several safety measures.

  • Assess renal function: adjust use in patients with impaired kidney function.
  • Evaluate cardiac history: avoid in patients with known QT prolongation.
  • Review allergy history: contraindicated in individuals with hypersensitivity to fluoroquinolones.
  • Use cautiously in the elderly: higher risk of tendon injury and CNS effects.
  • Monitor for tendon pain: discontinue if signs of tendonitis appear.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Moxifloxacin can interact with other medicines, affecting safety and efficacy.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: reduce absorption of moxifloxacin.
  • Antiarrhythmic agents (e.g., amiodarone): increase risk of QT prolongation.
  • Warfarin: may enhance anticoagulant effect, raising INR.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: combined use may increase tendon rupture risk.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may potentiate central nervous system side effects.

Frequently Asked Questions

Moloxin contains moxifloxacin, a fluoroquinolone antibiotic indicated for adult patients with community‑acquired pneumonia, acute bacterial sinusitis, and acute exacerbations of chronic bronchitis. It works by eliminating the bacteria responsible for these respiratory infections.

Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these targets, the drug prevents bacterial cell division, leading to bacterial death and resolution of the infection.

The specific dose and duration of Moloxin therapy are determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Patients should follow the prescriber’s instructions exactly.

Moxifloxacin is generally classified as contraindicated or not recommended during pregnancy and lactation unless the potential benefit outweighs the risk. Healthcare providers should evaluate the risk‑benefit profile before prescribing to pregnant or nursing women.

To request Moloxin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moloxin (moxifloxacin) offers broad‑spectrum coverage against both Gram‑positive and Gram‑negative bacteria, including atypical pathogens, which many older fluoroquinolones or macrolides may not fully address. Its once‑daily dosing and high lung tissue penetration make it a convenient option for severe community‑acquired infections.

Moloxin tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep the medication out of reach of children and do not use after the expiry date.

Moloxin is taken orally, usually as a whole tablet with or without food, unless the prescriber advises otherwise. The tablet should be swallowed with a full glass of water and not crushed or chewed unless specifically instructed.

Serious adverse events include tendon rupture, QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and hepatic injury. Patients should seek immediate medical attention if they experience symptoms like sudden tendon pain, palpitations, rash, or persistent diarrhea.

Moloxin is contraindicated in individuals with a known hypersensitivity to moxifloxacin or other fluoroquinolones, patients with a history of tendon disorders related to fluoroquinolone use, and those with established QT prolongation or certain cardiac arrhythmias. Caution is also advised for pregnant or breastfeeding women and the elderly.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT